SUPPLY CHAIN
CREATING SUPPLY CHAIN SOLUTIONS IN ONCOLOGY WITH SERVIER
Eric Lemay , head of global external manufacturing at Servier , manages pharmaceutical supply chain challenges to support cancer patients
WRITTEN BY : HELEN ADAMS
Servier Pharmaceuticals , a commercial stage , privately held United States pharmaceutical company that was launched by Servier Group , is committed to finding solutions that will address today ' s challenges . The company ' s oncology portfolio of innovative medicines is designed to bring more life-saving treatments to a greater number of patients , across the entire spectrum of disease and in a variety of tumour types . Last year , Servier Group hit a revenue of € 4.7bn .
Eric Lemay is the head of global external manufacturing at Servier .
“ I ' m responsible for the end-to-end delivery of Servier ’ s portfolio products that are manufactured outside of our internal manufacturing network , at what we can call contract manufacturing organisations ,” said
Lemay . “ My team is responsible for the dayto-day management and oversight of all production activities , such as forecasting , batch production , release of the product and shipment . I ' ve been doing external manufacturing for almost 20 years – it ’ s my passion . I really enjoy the science aspect , but I really enjoy the business and the operations sides , too .”
Servier is dedicated to bringing the promise of tomorrow to patients , with one of its key medicines in the USA being a paediatric oncology drug .
“ It really brings things home for you , in terms of the who and the why behind the work we ’ re doing ,” said Lemay . “ It connects the dots in terms of manufacturing and making a medicine that is essentially saving children ' s lives . So for me it ’ s extremely rewarding .”
96 July 2022